StonvexLoading…
StonvexStonvexStonvexCore line items from MRCY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-27 | Annual 2024 2024-06-28 | Annual 2023 2023-06-30 | Annual 2022 2022-07-01 |
|---|---|---|---|---|
Revenue | $912.02M | $835.27M | $973.88M | $988.20M |
Operating Income | $-19.63M | $-147.75M | $-21.68M | $31.61M |
Net Income | $-37.90M | $-137.64M | $-28.34M | $11.28M |
EPS (Diluted) | $-0.65 | $-2.38 | $-0.50 | $0.20 |
Total Assets | $2.43B | $2.38B | $2.39B | $2.30B |
Total Liabilities | $961.30M | $906.13M | $824.68M | $767.23M |
Cash & Equivalents | $309.10M | $180.52M | $71.56M | $65.65M |
Free Cash Flow OCF − CapEx | $119.05M | $26.09M | $-60.05M | $-46.52M |
Shares Outstanding | 59.00M | 58.09M | 56.96M | 55.68M |